HAL (France)
open access
Molecular plating for targetry: proof of concept using natGd(p,x)155Tb cross section measurements
he production of radionuclides for nuclear medicine is crucial for advancements in both diagnosis and therapy. 155Tb stands out as a promising candidate for SPECT imaging and as counterpart of the therapeutic radionuclide 161Tb in a theranostics approach. This work focuses on the gadolinium target f
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)#1365876
- Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI#1210939
- A Study to Compare the Safety and Imaging Pattern of Cyclotron-produced Technetium (CTC) vs. Generator-produced Technetium (G-PERT) in People With Thyroid Disorders Who Need Surgery#1072219
- SPECT/CT imaging in thyroid eye disease: an emerging role in assessing sub-clinical activity.#653363
- Interest of the SPECT-CT Scan SUVspect in the New Generation of Gamma-cameras With Semiconductor#1244274
Record · ID 1203757
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive